Fig 1: Effect of ADMSCs-derived exosomes on DOX/Trz-induced cardiac DNA damage and apoptosis: (A) Topoisomerase 2 beta (Top2b) and (B) p53 concentration by ELISA. Results are expressed as mean ± SEM; and (C) mRNA levels of cardiac Bax, Bcl-2, Bax/Bcl2 ratio, and PUMA. Data are expressed as median (maximum, minimum). *, significant compared to Group I at p ˂ 0.05; **, significant compared to Group I at p ˂ 0.01; ***, significant compared to Group I at p ˂ 0.001; #, significant compared to Group II at p ˂ 0.05; ##, significant compared to Group II at p ˂ 0.01; $, significant compared to Group III at p ˂ 0.05; n = 6.
Fig 2: Graph illustrating the impact of diazinon and naringenin on apoptotic markers (A) P53, (B) Bax, (C) caspase-9, (D) caspase-8, (E) caspase-3, and (F) Bcl-2. ^ p means against normal rats, ! p versus diazinon-treated rats.
Supplier Page from Thermo Fisher Scientific for Human/Mouse/Rat p53 ELISA Kit